Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
J-TALC2 phase II pleurodesis study for secondary intractable pneumothorax with sterile graded talc
jRCT1091220272Phase 2Completed
- Sponsor
- National Hospital Organization Nagoya Medical Center
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of talc in pneumothorax, sponsored by National Hospital Organization Nagoya Medical Center. Primary endpoint: Presence or absence of chest tube removal. Started Jan 2017; status: completed.
02
Drugs
talc
03
Conditions
pneumothorax
Beyond the preview
Go deeper on jRCT1091220272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220272.